Revolution Medicines' RASONQUE is the first broad RAS-targeted pill for metastatic pancreatic cancer, nearly doubling median survival to 13.2 months. The catch: $39,800 a month.
Broadcom sold $16.7B of custom AI chips in one quarter, up 221%, with Google, Anthropic and OpenAI on the roster. So why did the stock fall?
Miami's Felix closed a $200M Series C led by a16z and General Catalyst at a ~$1.4B valuation, moving $8B in remittances for 6M+ users through a WhatsApp chat.
The Pentagon opened GenAI.mil to 3 million personnel with ChatGPT Mil and Grok for Government at IL5 clearance. Anthropic's Claude is the one vendor left out.
Starcloud closed a $250M Series A extension at a $2.3B valuation to run Nvidia GPUs in orbit. One H100 is already up there; the FCC filing asks for 88,000 satellites.
Nvidia is paying $12.93 billion for Hugging Face, the home of open-source AI and 18 million developers. It's the chipmaker's largest acquisition ever, and it just bought the town square where every AI builder meets.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
Revolution Medicines' RASONQUE is the first broad RAS-targeted pill for metastatic pancreatic cancer, nearly doubling median survival to 13.2 months. The catch: $39,800 a month.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
